How inflated published prices affect drugs considered for the federal upper limit list.

Medicaid drug price comparisons : average sales price to average wholesale price.
Published: (2005)

Medicaid drug price comparisons : average manufacturer price to published prices.
Published: (2005)

Medicaid's use of revised average wholesale prices.
Published: (2001)

Comparing pharmacy reimbursement : Medicare Part D to Medicaid.
Published: (2009)

The impact of high-priced generic drugs on Medicare and Medicaid.
Published: (1998)

Generic drug utilization in state Medicaid programs.
Published: (2006)

Medicaid rebates for physician-administered drugs.
Published: (2004)

Deficiencies in the 340B drug discount program's database.
Published: (2004)

Deficiencies in the oversight of the 340B drug pricing program.
Published: (2005)

Replacing average wholesale price : Medicaid drug payment policy.
Published: (2011)

States' use of new drug pricing data in the Medicaid program.
Published: (2007)

States' collection of Medicaid rebates for physician-administered drugs.
Published: (2011)

States' collection of rebates for drugs paid through Medicaid managed care organizations.
Published: (2012)

Experiences of health maintenance organizations with pharmacy benefit management companies.
Published: (1997)

What to do if you no longer automatically qualify for extra help with Medicare prescription drug costs.
Published: (2017)

What to do if you no longer automatically qualify for extra help with Medicare prescription drug costs.
Published: (2018)

Qué hacer si ya no califica automáticamente para la Ayuda Adicional con los costos de la cobertura de recetas médicas de Medicare.
Published: (2018)

Medicaid brand-name drugs : rising prices are offset by manufacturer rebates.
Published: (2011)

Calculation of volume-weighted average sales price for Medicare Part B prescription drugs.
Published: (2006)

Medicare reimbursement for lupron.
Published: (2004)

Centers for Medicare & Medicaid Services audits of Medicare Part D bids.
Published: (2008)

Higher rebates for brand-name drugs result in lower costs for Medicaid compared to Medicare Part D.
Published: (2011)

Medicaid recovery of pharmacy payments from liable third parties.
Published: (2001)

Early implementation of MMA : status report of the state health insurance assistance programs /
Published: (2006)

Monitoring Medicare Part B drug prices : a comparison of average sales prices to average manufacturer prices.
Published: (2006)

Seniors feeling the squeeze : rising drug prices and the Part D program : hearing before the Special Committee on Aging, United States Senate, One Hundred Eleventh Congress, second session, Washington, DC, March 17, 2010.
Published: (2010)

Prescription drug discount coupons and patient assistance programs (PAPs) /
by: Kirchhoff, Suzanne M.
Published: (2018)

Courts split on whether private individuals can sue to challenge states' medicaid defunding decisions : considerations for congress (part I of II) /
by: Shen, Wen S.
Published: (2018)

Medicaid, getting started /
Published: (2009)

Courts split on whether private individuals can sue to challenge states' medicaid defunding decisions : considerations for congress (part II of II) /
by: Shen, Wen S.
Published: (2018)

Update : excessive Medicare reimbursement for albuterol.
Published: (2004)

Excessive Medicare reimbursement for ipratropium bromide.
Published: (2002)

Update : excessive Medicare reimbursement for ipratropium bromide.
Published: (2004)

Medicare reimbursement for new end stage renal disease drugs.
Published: (2006)

Memorandum report : Medicare Part D pharmacy discounts for 2008.
Published: (2010)

Fin de la interrupción de la cobertura.
Published: (2018)